TABLE 3.
Pulmonary arterial hypertension |
Primary pulmonary hypertension |
Sporadic disorder |
Familial disorder |
Related conditions |
Collagen vascular disease |
Congenital systemic-to-pulmonary shunt |
Portal hypertension |
HIV infection |
Drugs and toxins |
Anorectic agents (appetite suppressants) |
Others |
Persistent pulmonary hypertension of the newborn |
Others |
Pulmonary venous hypertension |
Left-sided atrial or ventricular heart disease |
Left-sided valvular heart disease |
Extrinsic compression of central pulmonary veins |
Fibrosing mediastinitis |
Adenopathy and/or tumours |
Pulmonary veno-occlusive disease |
Others |
Pulmonary hypertension associated with disorders of the respiratory system and/or hypoxemia |
Chronic obstructive pulmonary disease |
Interstitial lung disease |
Sleep-disordered breathing |
Alveolar hypoventilation disorders |
Chronic exposure to high altitudes |
Neonatal lung disease |
Alveolar-capillary dysplasia |
Others |
Pulmonary hypertension resulting from chronic thrombotic and/or embolic disease |
Thromboembolic obstruction of proximal pulmonary arteries |
Obstruction of distal pulmonary arteries |
Pulmonary embolism (thrombus, tumour, ova and/or parasites, foreign material) |
In situ thrombosis |
Sickle cell disease |
Pulmonary hypertension resulting from disorders directly affecting the pulmonary vasculature |
Inflammatory conditions |
Schistosomiasis |
Sarcoidosis |
Others |
Pulmonary capillary hemangiomatosis |
Adapted with permission from reference 139